Latest statistics and disclosures from Foresite Capital Management V's latest quarterly 13F-HR filing:
- Top 5 stock holdings are CGEM, Quantum Si, ACRS, KNTE, GMTX, and represent 61.87% of Foresite Capital Management V's stock portfolio.
- Added to shares of these 2 stocks: Quantum Si (+$29M), 23andme Holding (+$8.2M).
- Started 2 new stock positions in Quantum Si, 23andme Holding.
- Reduced shares in these 7 stocks: OLK (-$7.2M), PHVS (-$5.6M), ALXO, LSAQ, Therapeutics Acquisition Cor, Consonance-HFW Acquisition Corp., IMVT.
- Sold out of its positions in Consonance-HFW Acquisition Corp., IMVT, LSAQ, OLK, Therapeutics Acquisition Cor.
- Foresite Capital Management V was a net buyer of stock by $9.7M.
- Foresite Capital Management V has $254M in assets under management (AUM), dropping by -25.28%.
- Central Index Key (CIK): 0001792206
Tip: Access up to 7 years of quarterly data
Positions held by Foresite Capital Management V consolidated in one spreadsheet with up to 7 years of dataDownload as csv Download as Excel
Portfolio Holdings for Foresite Capital Management V
Companies in the Foresite Capital Management V portfolio as of the June 2021 quarterly 13F filing
|Company (Ticker)||Portfolio Weight||Valued At||Change in Shares||Share Count||Share Price|
|Cullinan Oncology (CGEM)||27.7||$70M||2.7M||25.75|
|Quantum-Si Incorporated Com Cl A||11.3||$29M||NEW||2.3M||12.26|
|Aclaris Therapeutics (ACRS)||8.7||$22M||1.3M||17.56|
|Kinnate Biopharma (KNTE)||8.0||$20M||875k||23.28|
|Gemini Therapeutics (GMTX)||6.2||$16M||2.4M||6.47|
|Relay Therapeutics (RLAY)||5.8||$15M||400k||36.59|
|Alx Oncology Hldgs (ALXO)||5.0||$13M||-27%||231k||54.68|
|Nurix Therapeutics (NRIX)||4.7||$12M||452k||26.53|
|Hims & Hers Health Com Cl A (HIMS)||4.5||$12M||1.1M||10.89|
|Population Health Investment Unit (PHICU)||3.8||$9.7M||960k||10.15|
|23andMe Holding Com Cl A||3.2||$8.2M||NEW||700k||11.69|
|Pharvaris N V (PHVS)||2.7||$6.8M||-45%||364k||18.63|
|FS Development Corp. II Com Cl A (FSII)||2.4||$6.0M||603k||9.98|
|Research Alliance Corp. II Com Cl A (RACB)||2.0||$5.1M||500k||10.14|
Setup an alert
Foresite Capital Management V will file the next quarterly 13-HR in about 2 months. Would you like to be notified?
|Bctg Acquisition Corp (BCTG)||1.8||$4.6M||400k||11.38|
|Lucira Health (LHDX)||1.3||$3.2M||485k||6.64|
|Helix Acquisition Corp. Com Cl A (HLXA)||1.0||$2.6M||250k||10.35|
Past Filings by Foresite Capital Management V
SEC 13F filings are viewable for Foresite Capital Management V going back to 2020